We are live on ! Find out more
N

NanoDimension Portfolio holdings

AUM $24.7M
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-20.33%
1 Year Est. Return
-74.01%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$30.5M
AUM Growth
-$15.1M
Cap. Flow
-$7.12M
Cap. Flow %
-23.32%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
RNAC icon
Cartesian Therapeutics
RNAC
+$350K

Top Sells

Rank Stock Value
1
ICVX
Icosavax, Inc. Common Stock
ICVX
+$7.47M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWST icon
1
Twist Bioscience
TWST
$5.77B
$10.8M 35.22%
307,740
– –
ICVX
2
DELISTED
Icosavax, Inc. Common Stock
ICVX
$9.95M 32.57%
1,735,914
-957,858
-36% -$7.47M
RNAC icon
3
Cartesian Therapeutics
RNAC
$235M
$5.24M 17.16%
133,417
+11,820
+10% +$350K
SQZ
4
DELISTED
SQZ Biotechnologies Company
SQZ
$4.6M 15.05%
1,445,221
– –

Similar funds

AEPI
AH Equity Partners IV Menlo Park, California $24.5M AUM 73.4% 1-Year Est. Return
CVGI
Craft Ventures GP II San Francisco, California $24.1M AUM 83.06% 1-Year Est. Return
NVPX
Norwest Venture Partners XIII Palo Alto, California $25.8M AUM 76.52% 1-Year Est. Return
BAS
Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return
GX
Greylock XIII Menlo Park, California $27.6M AUM 53.47% 1-Year Est. Return
FCMI
Foresite Capital Management I Larkspur, California $21.4M AUM 80.48% 1-Year Est. Return
KL
Kokino LLC Stamford, Connecticut $28M AUM 16.9% 1-Year Est. Return
A
Atlassian San Francisco, California $21M AUM 71.86% 1-Year Est. Return

NanoDimension's Q2 2022 Portfolio in Review

As of Q2 2022, NanoDimension held 4 positions worth $30.5M, down 33% from $45.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

NanoDimension withdrew a net $7.12M in Q2 2022, reducing 1 holding. Its largest reduction was Icosavax, Inc. Common Stock, cutting an estimated $7.47M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, NanoDimension added an estimated $350K to Cartesian Therapeutics.

  • NanoDimension added most to Cartesian Therapeutics in Q2 2022, an estimated $350K increase.
  • NanoDimension's biggest Q2 2022 reduction was Icosavax, Inc. Common Stock, cutting an estimated $7.47M.
  • NanoDimension's ten largest holdings make up 100% of its $30.5M portfolio in Q2 2022.
  • NanoDimension opened 0 new positions and closed 0 in Q2 2022.
  • NanoDimension's portfolio value fell 33% quarter-over-quarter to $30.5M.

Based on NanoDimension's 13F filing for Q2 2022, filed 28 Jul 2022.